A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 9, 2014, Pages 5363-5371

  Reffuveille, Fany ^a   De La Fuente Nú̃nez, César ^a   Mansour, Sarah ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOFILM PEPTIDE 1018; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; PEPTIDE; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIUM ADHERENCE; BIOFILM; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; ENTEROBACTER; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PLANKTON; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA; SHORT COURSE THERAPY; STAPHYLOCOCCUS AUREUS; BACTERIUM; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PEPTIDES;

EID: 84906086738     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03163-14     Document Type: Article

References (22)

1. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322. http://dx.doi.org/10.1126/science.284.5418.1318. (Pubitemid 29289651)
2. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108. http://dx.doi.org/10.1038/nrmicro821. (Pubitemid 39490064)
3. Høiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PØ Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T. 2011. The clinical impact of bacterial biofilms. Int. J. Oral Sci. 3:55-65. http://dx.doi.org/10.4248/ IJOS11026.
4. Römling U, Balsalobre C. 2012. Biofilm infections, their resilience to therapy and innovative treatment strategies. J. Intern. Med. 272:541-561. http://dx.doi.org/10.1111/joim.12004.
5. de la Fuente-Núñez C, Reffuveille F, Fernández L, Hancock REW. 2013. Bacterial biofilm development as a multicelular adaptation: antibiotic resistance and new therapeutic strategies. Curr. Opin. Microbiol. 16:580-589. http://dx.doi.org/10.1016/j.mib.2013.06.013.
6. Driffield K, Miller K, Bostock JM, O'Neill AJ, Chopra I. 2008. Increased mutability of Pseudomonas aeruginosa in biofilms. J. Antimicrob. Chemother. 61:1053-1056. http://dx.doi.org/10.1093/jac/dkn044. (Pubitemid 351524449)
7. Hausner M, Wuertz S. 1999. High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl. Environ. Microbiol. 65:3710-3713. (Pubitemid 29399007)
8. de la Fuente-Núñez C, Reffuveille F, Haney EF, Strauss SK, Hancock REW. 2014. Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog. 10:e1004152. http://dx.doi.org/10.1371/journal. ppat.1004152.
9. Nguyen D, Joshi-Datar A, Lepine F, Bauerle E, Olakanmi O, Beer K, McKay G, Siehnel R, Schafhauser J, Wang Y, Britigan BE, Singh PK. 2011. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334:982-986. http://dx.doi.org/10.1126/ science.1211037.
10. Wiegand I, Hilpert K, Hancock REW. 2008. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3:163-175. http://dx.doi.org/10.1038/nprot.2007.521. (Pubitemid 351266501)
11. Fernández L, Gooderham WJ, Bains M, McPhee JB, Wiegand I, Hancock REW. 2010. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob. Agents Chemother. 54:3372-3382. http://dx.doi.org/10.1128/AAC.00242-10.
12. Hall MJ, Middleton RF, Westmacot D. 1983. The fractional inhibitory concentration (FIC) index as a measure of synergy. J. Antimicrob. Chemother. 11:427-433. http://dx.doi.org/10.1093/jac/11.5.427. (Pubitemid 13094077)
13. de la Fuente-Núñez C, Korolik V, Bains M, Nguyen U, Breidenstein EBM, Horsman S, Lewenza S, Burrows L, Hancock REW. 2012. Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob. Agents Chemother. 56: 2696-2704. http://dx.doi.org/10.1128/AAC.00064-12.
14. Gilbert P, Collier PJ, Brown MR. 1990. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob. Agents Chemother. 34:1865-1868. http://dx.doi.org/10.1128/AAC.34.10.1865. (Pubitemid 20290280)
15. Geiger T, Goerke C, Fritz M, Schäfer T, Ohlsen K, Liebeke M, Lalk M, Wolz C. 2010. Role of the (p)ppGpp synthase RSH, a RelA/SpoT homolog, in stringent response and virulence of Staphylococcus aureus. Infect. Immun. 78:1873-1883. http://dx.doi.org/10.1128/IAI.01439-09.
16. Levine C, Hiasa H, Marians KJ. 1998. DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochim. Biophys. Acta 1400:29-43. http://dx.doi.org/10. 1016/S0167-4781(98)00126-2. (Pubitemid 28475094)
17. Hashizume T, Ishino F, Nakagawa J, Tamaki S, Matsuhashi M. 1984. Studies on the mechanism of action of imipenem (N-formimidoylthienamycin) in vitro: binding to the penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa, and inhibition of enzyme activities due to the PBPs in E. coli. J. Antibiot. (Tokyo) 37:394-400. http://dx.doi.org/10.7164/antibiotics. 37.394. (Pubitemid 14129492)
18. Hayes MV, Orr DC. 1983. Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J. Antimicrob. Chemother. 12:119-126. http://dx.doi.org/10.1093/jac/12.2.119. (Pubitemid 13034142)
19. Colvin KM, Gordon VD, Murakami K, Borlee BR, Wozniak DJ, Wong GC, Parsek MR. 2011. The Pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa. PLoS Pathog. 7:e1001264. http://dx.doi.org/10.1371/journal.ppat.1001264.
20. de la Fuente-Núñez C, Reffuveille F, Fairfull-Smith KE, Hancock REW. 2013. Effect of nitroxides on swarming motility and biofilm formation, multicellular behaviors in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 57:4877-4881. http://dx.doi.org/10.1128/AAC.01381-13.
21. Bjarnsholt T, Ciofu O, Molin S, Givskov M, Høiby N. 2013. Applying insights from biofilm biology to drug development - can a new approach be developed? Nat. Rev. Drug Discov. 12:791-808. http://dx.doi.org/10.1038/nrd4000.
22. Hall-Stoodley L, Stoodley P. 2005. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol. 13:7-10. http://dx.doi.org/10.1016/j.tim.2004.11.004. (Pubitemid 40082390)